AI assistant
Sending…
CASTLE BIOSCIENCES INC — Director's Dealing 2021
Dec 15, 2021
32601_dirs_2021-12-14_f013bb97-7219-4897-b8b0-d3c3db5d86d9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-12-10
Reporting Person: Spiess Bernhard E. (Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-10 | Common Stock | M | 1500 | — | Acquired | 15062 | Direct |
| 2021-12-10 | Common Stock | F | 366 | $40.52 | Disposed | 14696 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-10 | Restricted Stock Units | $ | M | 1500 | Disposed | Common Stock (1500.0) | Direct |
Footnotes
F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.
F2: On December 10, 2020, the Reporting Person was granted 6,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.
More from CASTLE BIOSCIENCES INC
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 26
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Jan 22
Director's Dealing
2026
Jan 14